US Broker Ratings

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a Promising 31% Upside

For investors eyeing opportunities within the biopharmaceutical sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing option. With a market capitalization of $6.46 billion, this biotechnology firm focuses on the..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Player with 72% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a formidable player in the biotechnology sector, distinguished by its commitment to developing groundbreaking therapies for cancer treatment. With a market capitalization of..

Becton, Dickinson and Company (BDX): Evaluating Growth Potential with a 24% Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to hold a commanding presence in the Medical Instruments & Supplies industry. With a market capitalization of..

argenx SE (ARGX) Stock Analysis: Unveiling a 27% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector may find argenx SE (NASDAQ: ARGX) to be a compelling opportunity. With a market cap of $50.4 billion, this Netherlands-based company..

Henry Schein, Inc. (HSIC) Stock Analysis: Healthcare Distributor with 17.52% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the medical distribution industry, stands as a significant player in the healthcare sector with a market capitalization of $8.45 billion. Known for..

The Cigna Group (CI) Stock Analysis: A Healthcare Giant with a Promising 19% Upside

For investors seeking opportunities in the healthcare sector, The Cigna Group (CI) presents a compelling case. With a robust market capitalization of $75.72 billion, Cigna operates primarily in the United..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with 7.95% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to catch the eye of investors, presenting a potential upside of 7.95% based on current analyst ratings. As..

BeOne Medicines Ltd. (ONC) Investor Outlook: A Biotech Powerhouse with a 32.64% Upside Potential

BeOne Medicines Ltd. (ONC), based in Basel, Switzerland, is making waves in the biotechnology sector with its robust pipeline of innovative cancer therapies. With a market capitalization of $32.19 billion,..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential with a 33.82% ROE

Illumina, Inc. (NASDAQ: ILMN) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in San Diego, California, the company is a leading..

Encompass Health Corporation (EHC) Stock Analysis: A 35% Upside Potential Beckons Investors

Encompass Health Corporation (NYSE: EHC), a leader in the healthcare sector specializing in medical care facilities, presents an intriguing opportunity for investors with a potential upside of 35.20%. With its..

BioNTech SE (BNTX) Investor Outlook: Navigating a 33% Potential Upside Amidst Biotech Volatility

BioNTech SE (NASDAQ: BNTX) has captured global attention, not only for its groundbreaking mRNA COVID-19 vaccine but also for its ambitious oncology pipeline. As investors consider the stock’s current positioning,..

Tenet Healthcare Corporation (THC) Stock Analysis: A 40% Upside Potential Beckons Investors

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. medical care facilities industry, presents a compelling opportunity for investors with its robust growth potential and strategic positioning in..

The Cooper Companies, Inc. (COO) Stock Analysis: Potential 45.59% Upside Driven by Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO) stands out in the healthcare sector with its innovative approach to medical instruments and supplies, particularly focusing on contact lenses and women’s health products...

ICON plc (ICLR) Stock Analysis: Unveiling a 13.55% Upside Potential for Investors

ICON plc (NASDAQ: ICLR), a leading clinical research organization based in Dublin, Ireland, is drawing the attention of savvy investors with its promising 13.55% potential upside. As a key player..

Molina Healthcare Inc (MOH): Analyst Consensus and Stock Analysis Reveal Limited Upside Potential

Molina Healthcare Inc (NYSE: MOH) presents a mixed bag for investors, as its current financial and stock performance metrics reveal both challenges and opportunities in the healthcare sector. With a..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 12.69% Upside Potential and Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, specifically within the drug manufacturing industry, is a company that continues to capture the attention of investors. With a current..

Align Technology, Inc. (ALGN) Stock Analysis: Aiming for a 27.79% Upside with Analyst Support

Align Technology, Inc. (NASDAQ: ALGN) has carved a niche for itself in the healthcare sector, specifically within the medical instruments and supplies industry. Best known for its Invisalign clear aligners..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Biotech Giant with a 260% Revenue Growth

Moderna, Inc. (NASDAQ: MRNA) stands as a beacon of innovation in the biotechnology sector, renowned for its pioneering work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, Moderna has..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 29.63% Potential Upside

Alcon Inc. (NYSE: ALC), a Swiss-based giant in the healthcare sector, particularly in the medical instruments and supplies industry, offers investors a compelling opportunity with a potential upside of 29.63%...

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 19.31% Potential Upside in the Diagnostics Sector

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry, offering a comprehensive range of laboratory services. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds